Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2024-11-14 Earnings Release
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
PDS: Clinical Programs Update, 3rd Quarter Results
Earnings Release Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 3176M' and the closing section referencing RNS and the London Stock Exchange). The content primarily reports on the business update and 'Third Quarter 2024 Financial Results' of a portfolio company, PDS Biotechnology Corporation, which is relevant to the reporting company, EMV Capital PLC. Since this is an announcement reporting on the financial results of a portfolio company, it functions as an Earnings Release (ER) for EMV Capital's investment activity, or more broadly, a significant corporate update. However, the structure strongly resembles a standard regulatory news service release that summarizes key operational and financial highlights for a period (Q3 2024). Given the presence of specific financial figures (net loss, operating expenses) for the quarter, it aligns best with an Earnings Release (ER) or, if viewed as a general regulatory update, RNS. Since it contains the core financial highlights for a period, ER is a strong candidate. However, because this is an announcement *about* a portfolio company's results, and it is distributed via RNS, the most accurate classification for the *filing itself* (the announcement) is RNS, as it is a general regulatory announcement that doesn't fit the strict definition of a full 10-K or IR, and it is not explicitly an 'Earnings Release' (ER) for EMV Capital itself, but rather a report on a holding. Given the context of RNS distribution and the nature of the content being a summary of updates and quarterly figures, RNS is the safest and most encompassing category for this type of regulatory news wire filing. Q3 2024
2024-11-14 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification filed with the RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the FCA. The content explicitly details 'Director/PDMR Shareholding' transactions, specifically purchases of ordinary shares by the CEO and an Executive Director. This type of insider transaction disclosure, mandated under UK Market Abuse Regulation, directly corresponds to the definition of Director's Dealing. Therefore, the appropriate filing code is DIRS.
2024-10-08 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification released via RNS (London Stock Exchange news service) concerning a transaction by a Director/PDMR (Person Discharging Managerial Responsibilities). Specifically, it details the purchase of 25,000 ordinary shares by Dr Jonathan Robinson, a Senior Independent Director. This type of filing, reporting personal share transactions by company directors and executives, directly matches the definition for Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2024-10-03 English
PDS: 36-Month Overall Survival Rate announcement
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and is dated '02 October 2024' for 'immediate release'. It contains a press release format announcing clinical trial data updates for a portfolio company (PDS Biotech) by the reporting entity (EMV Capital PLC). The text concludes with standard disclaimers referencing RNS and the London Stock Exchange, confirming it is a regulatory news service announcement. Since this is a general announcement of corporate news/developments that doesn't fit the specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2024-10-02 English
Interim Results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Results for the six months ended 30 June 2024' and contains detailed financial data, including Assets Under Management (AUM), income statements, and operational highlights for the specified period. It is a comprehensive report of financial performance for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-30 English
Name change and AIM Rule 26 website
Regulatory Filings Classification · 100% confidence The document is an official announcement released via RNS (RNS Number : 6848F) on September 26, 2024, by EMV Capital PLC (formerly NetScientific plc). The core content announces a name change, the associated change in TIDM code, and the update of the company website to comply with AIM Rule 26. This type of mandatory, timely disclosure to the market, which is not a full financial report (like 10-K or IR), a specific transaction (like DIV or POS), or a management change (MANG), fits best under the general regulatory announcement category provided by the London Stock Exchange's news service (RNS). Since it is a specific regulatory update that doesn't fit the other specialized codes (like DIRS, DVA, or CAP), RNS is the most appropriate classification.
2024-09-26 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.